Medtronic is releasing in the U.S. and Europe its new Pacific Plus percutaneous transluminal angioplasty (PTA) balloon catheter following both FDA and CE Mark approvals.
The catheter is designed to treat narrowing within renal, iliac, iliofemoral, femoral, popliteal and infrapopliteal arteries. It has a hydrophilic coating and the company promises improved navigation and crossability through the obstruction.
Spanning a broad size matrix, the Pacific Plus PTA catheter is an over-the-wire (OTW) peripheral balloon that is compatible with both 0.014-inch and 0.018-inch guidewires and 4 French or 5 French introducer sheaths. It is available in shaft lengths of 90cm, 130cm and 180cm and catheter lengths ranging from 20mm to 120mm for balloon diameters 2.0-7.0mm, with a 150mm catheter also available on balloon diameters 2.0-3.5mm.
The new device complements the existing Pacific Xtreme PTA catheter, which is available in lengths ranging from 150mm to 300mm for a variety of balloon diameters.